Stock chart
Ticker: VIGL Exchange: NSM


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2024-12-19 2024-12-19 B Purchase

Magovcevic-Liebisch Ivana

President and CEO

Executive Director
5,000 +2.3%
1.68
USD 8,400
5,000 +2.3% 1.68 USD 8,400
2024-12-19 2024-12-19 B Purchase

Budd Haeberlein Samantha L.

Non-Executive Director
12,000 +inf%
1.71
USD 20,520
12,000 +inf% 1.71 USD 20,520
2024-12-18 2024-12-18 B Purchase

Magovcevic-Liebisch Ivana

President and CEO

Executive Director
5,000 +2.4%
1.67
USD 8,350
5,000 +2.4% 1.67 USD 8,350
2024-12-05 2024-12-05 B Purchase

Magovcevic-Liebisch Ivana

President and CEO

Executive Director
5,000 +2.4%
2.34
USD 11,700
5,000 +2.4% 2.34 USD 11,700
2023-11-20 2023-11-20 B Purchase

Magovcevic-Liebisch Ivana

President and CEO

Executive Director
4,000 +2.0%
3.75
USD 15,000
4,000 +2.0% 3.75 USD 15,000
2022-11-22 2022-11-18 PS Planned sale

Papapetropoulos Spyros

Chief Medical Officer

Officer
300 -7.0%
14.00
USD 4,200
300 -7.0% 14.00 USD 4,200
2022-05-17 2022-05-17 B Purchase

Thorp Clay

Non-Executive Director
14,893 +1.0%
2.97
USD 44,189
14,893 +1.0% 2.97 USD 44,189
2022-05-17 2022-05-16 B Purchase

Thorp Clay

Non-Executive Director
21,802 +1.4%
2.76
USD 60,221
21,802 +1.4% 2.76 USD 60,221
2022-05-06 2022-05-05 B Purchase

Thackaberry Evan

SVP, Head of Early Development

Officer
1,500 +inf%
4.00
USD 6,000
1,500 +inf% 4.00 USD 6,000
2022-05-04 2022-05-03 B Purchase

Verni Christopher

General Counsel

Officer
4,000 +inf%
3.77
USD 15,074
4,000 +inf% 3.77 USD 15,074
2022-05-04 2022-05-03 B Purchase

Magovcevic-Liebisch Ivana

President and CEO

Executive Director
1,000 +0.5%
3.94
USD 3,940
1,000 +0.5% 3.94 USD 3,940
2022-05-04 2022-05-03 B Purchase

Ziolkowski Jennifer Lynn

Chief Financial Officer

Officer
4,000 +inf%
3.77
USD 15,098
4,000 +inf% 3.77 USD 15,098
2022-05-04 2022-05-03 B Purchase

Papapetropoulos Spyros

Chief Medical Officer

Officer
4,000 +inf%
3.40
USD 13,591
4,000 +inf% 3.40 USD 13,591
2022-05-04 2022-05-02 B Purchase

Magovcevic-Liebisch Ivana

President and CEO

Executive Director
4,000 +2.0%
3.61
USD 14,439
4,000 +2.0% 3.61 USD 14,439
2022-03-28 2022-03-28 B Purchase

Thorp Clay

Non-Executive Director
3,000 +inf%
7.20
USD 21,604
3,000 +inf% 7.20 USD 21,604
2022-01-11 2022-01-11 B Purchase

Booth Bruce

Non-Executive Director
535,000 +12.5%
14.00
USD 7,490,000
535,000 +12.5% 14.00 USD 7,490,000
2022-01-11 2022-01-11 B Purchase

Northpond Ventures GP, LLC

Large shareholder
355,000 +34.5%
14.00
USD 4,970,000
355,000 +34.5% 14.00 USD 4,970,000
2022-01-11 2022-01-11 B Purchase

Vida Ventures GP III, L.L.C.

Large shareholder
3,852 +50.1%
14.00
USD 53,928
3,852 +50.1% 14.00 USD 53,928
2022-01-11 2022-01-11 B Purchase

Vida Ventures GP III, L.L.C.

Large shareholder
1,671,148 +50.1%
14.00
USD 23,396,072
1,671,148 +50.1% 14.00 USD 23,396,072
2022-01-11 2022-01-11 B Purchase

Vitorovic Stefan

Non-Executive Director
3,852 +50.1%
14.00
USD 53,928
3,852 +50.1% 14.00 USD 53,928
2022-01-11 2022-01-11 B Purchase

Vitorovic Stefan

Non-Executive Director
1,671,148 +50.1%
14.00
USD 23,396,072
1,671,148 +50.1% 14.00 USD 23,396,072
2022-01-11 2022-01-11 B Purchase

Atlas Venture Fund XII, L.P.

Large shareholder
535,000 +12.5%
14.00
USD 7,490,000
535,000 +12.5% 14.00 USD 7,490,000
2022-01-11 2022-01-11 B Purchase

Thorp Clay

Non-Executive Director
265,000 +21.1%
14.00
USD 3,710,000
265,000 +21.1% 14.00 USD 3,710,000
// ... existing code ... // ... rest of the file ...